Roche to make $4.3bn gene therapy acquisition

25-02-2019

Roche to make $4.3bn gene therapy acquisition

Grand Warszawski / Shutterstock.com

Switzerland-based Roche will buy gene therapy company Spark Therapeutics in a $4.3 billion deal. 


Roche, mergers and acquisitions, M&A, gene therapy, Spark Therapeutics, genetic diseases, haemophilia, blindness

LSIPR